Heterozygous Mutations in TREX1 Cause Familial Chilblain Lupus and Dominant Aicardi-Goutières Syndrome
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
TREX1 constitutes the major 3'-->5' DNA exonuclease activity measured in mammalian cells. Recently, biallelic mutations in TREX1 have been shown to cause Aicardi-Goutieres syndrome at the AGS1 locus. Interestingly, Aicardi-Goutieres syndrome shows overlap with systemic lupus erythematosus at both clinical and pathological levels. Here, we report a heterozygous TREX1 mutation causing familial chilblain lupus. Additionally, we describe a de novo heterozygous mutation, affecting a critical catalytic residue in TREX1, that results in typical Aicardi-Goutieres syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“TREX1 mutations have been identified in SLE115 and familial chilblain lupus116, implicating TREX1 as a safeguard against autoimmune inflammation.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [116]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Type I Interferon in Systemic Lupus Erythematosus and Other Autoimmune Diseases
Banchereau, J., & Pascual, V. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.010 · Cited by 963
Crow, Y. J., Hayward, B. E., Parmar, R., Robins, P., Leitch, A., Ali, M., Black, D. N., van Bokhoven, H., Brunner, H. G., Hamel, B. C., et al. (2006) · Nature Genetics · doi:10.1038/ng1845 · Cited by 903 · cited 5×
“3), comparable to the level seen in cells from unaffected heterozygous parents of subjects with recessive AGS.6 Our previous analyses of AGS-affected patients with biallelic TREX1 mutations indicated that AGS at the AGS1 locus results from an abrogation of TREX1 enzyme activity.6 The TREX1 protein functions as a dimer…”
BackgroundSelf-citationOnline Mendelian Inheritance in Man 'OMIM'.
Amladi, S. (2003) · PubMed · Cited by 875
Crow, Y. J., Leitch, A., Hayward, B. E., Garner, A., Parmar, R., Griffith, E., Ali, M., Semple, C., Aicardi, J., Babul-Hirji, R., et al. (2006) · Nature Genetics · doi:10.1038/ng1842 · Cited by 675
Self-citationMutation of DNASE1 in people with systemic lupus erythematosus
Yasutomo, K., Horiuchi, T., Kagami, S., Tsukamoto, H., Hashimura, C., Urushihara, M., & Kuroda, Y. (2001) · Nature Genetics · doi:10.1038/91070 · Cited by 596
Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages
Kawane, K., Ohtani, M., Miwa, K., Kizawa, T., Kanbara, Y., Yoshioka, Y., Yoshikawa, H., & Nagata, S. (2006) · Nature · doi:10.1038/nature05245 · Cited by 470 · cited 1×
“Of note in the context of AGS, mutations in DNase I are associated with a lupus phenotype,(22) and mice deficient in DNase II accumulate undigested DNA in macrophages, with consequent IFN-b up-regulation, and recapitulate the clinical and immunological phenotype of rheumatoid arthritis.(23) We have suggested(6) that A…”
BackgroundMorita, M., Stamp, G., Robins, P., Dulic, A., Rosewell, I., Hrivnak, G., Daly, G., Lindahl, T., & Barnes, D. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6719-6727.2004 · Cited by 380 · cited 2×
“Lymphoblastoid cell lines were established from affected individuals, and TREX1 exonuclease activity in cell extracts was measured, as described elsewhere, with use of a polydeoxynucleotide substrate.(3) Extracts of control lymphoblastoid cell lines exhibited readily detected TREX1 activity.”
BackgroundMethodSelf-citationMazur, D. J., & Perrino, F. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19655 · Cited by 276
Self-citationChowdhury, D., Beresford, P. J., Zhu, P., Zhang, D., Sung, J.-S., Demple, B., Perrino, F. W., & Lieberman, J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.005 · Cited by 264
Self-citationA human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein
Hoss, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.13.3868 · Cited by 170 · cited 3×
“Despite its position within the EXO I domain, one of three sequence motifs containing four acidic residues participating in the coordination of divalent metal ions necessary for catalysis—the phenylalanine at position 17—is not conserved in mouse Trex1 or the related human TREX2.”
BackgroundSelf-citation
Cited by
Items 301–400 of 404
Hol, E. M., Dykstra, W., Chevalier, J., Cuadrado, E., Bugiani, M., Aronica, E., & Verkhratsky, A. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19102-2.00032-6 · Cited by 4
Immunodeficiencies and the Rheumatic Diseases
Legger, G. E., Wulffraat, N. M., & van Montfrans, J. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-24145-8.00046-6 · Cited by 3
Aicardi‐Goutières syndrome with muscle involvement in early infancy
Deigendesch, N., Morales-Gonzalez, S., Weschke, B., Goebel, H. H., Schuelke, M., & Stenzel, W. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12454 · Cited by 3
Hodgkin lymphoma in an individual with TREX1‐mediated Aicardi Goutières syndrome
Gavazzi, F., Fraser, J. L., Bloom, M. D., Tochen, L. S., Rhee, J., Kwan, M., Victoria, T., Teachey, D. T., Ho, C., Vanderver, A. L., et al. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.29322 · Cited by 3
Mendelian disorders of immunity related to an upregulation of type I interferon
Frémond, M., & Crow, Y. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816768-7.00032-6 · Cited by 3
Self-citationTacke, U., & Korinthenberg, R. (2008) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-008-1882-9 · Cited by 3
Kuhn, A., Böhm, M., & Luger, T. A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-374994-9.10027-0 · Cited by 3
Host DNA Induced Inflammation and Autoimmune Diseases
Pandey, S., & Kawai, T. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-404732-7.00005-8 · Cited by 3
Lee‐Kirsch, M. A., Aringer, M., & Kuhn, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7849-2_2 · Cited by 3
“It is caused by heterozygous mutations of the TREX1 gene encoding three prime repair exonuclease [ 3 , 4 ].”
BackgroundHosseini, S. A., & Labilloy, A. (2019) · StatPearls · Cited by 4
McMahan, Z. H., & Paik, J. J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1526-2_11 · Cited by 3
Cutaneous Lupus Erythematosus: Epidemiology, Association with SLE and Comorbidity
Grönhagen, C. M. (2012) · Figshare · Cited by 4
Vanmolkot, K. R. J., Terwindt, G. M., Frants, R. R., Haan, J., van den Maagdenberg, A., & Ferrari, M. D. (2008) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01511.x · Cited by 5
TREX1 enables viral entry in intestinal epithelia via immunity-independent control of endocytosis
Liu, X., Guo, H., Ni, F., Yang, W., Tang, Y., Xia, H., Yu, X., Zhang, L., & Wei, W. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116611 · Cited by 2
Rioux, B., McGlasson, S. L., Forbes, D., Reid, K. R., Klingseisen, A., Berry, J. S., Dhaun, N., Ng, W., Whiteley, W., & Hunt, D. P. J. (2026) · Nature Communications · doi:10.1038/s41467-025-67832-z · Cited by 2
“Parents of children with AGS appear to produce increased levels of antinuclear antibodies 4 , and dominant variants in TREX1 can cause a monogenic cutaneous form of lupus known as familial chilblain lupus (FCL) 5 .”
InfluentialBatignes, M., Luka, M., Jagtap, S., de Cevins, C., Nemazanyy, I., Leib, J., Fali, T., Pierga, A., Zarhrate, M., García-Paredes, V., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69979-9 · Cited by 4
Different clinical manifestations of three prime repair exonuclease 1 mutation: A case series
İncecik, F., Balcı, S., Ekinci, R. M. K., Herguner, O. M., Bişgin, A., & Yilmaz, M. (2019) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_469_18 · Cited by 2
“Heterozygous loss-of-function mutations in TREX1 and SAMHD1 and heterozygous gain-of-function mutations in STING have been reported in patients with FCL, so far.[17-19]”
To cleave or not and how? The DNA exonucleases and endonucleases in immunity
Lu, M., Wu, J., Gao, Q., Jin, R., An, C., & Ma, T. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101219 · Cited by 4
“12,13,61 A common feature of these diseases is the reduced 3 0 5 0 nucleic acid exonuclease activity of the mutant TREX1.”
Mouse models of type I interferonopathies
Luca, D., & Kato, H. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae187 · Cited by 2
“Dominant mutations in the exonuclease domains (such as D18N) are associated with familial chilblain lupus (FCL) [35, 36], heterozygous missense mutations throughout the gene are associated with systemic lupus erythematosus (SLE) [37, 38], and heterozygous frameshift mutations in the C-terminus are…”
Bankers, L., Miller, C. M., Liu, G., Thongkittidilok, C., Morrison, J. H., & Poeschla, E. M. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901421 · Cited by 2
The role of kynurenine pathway aryl hydrocarbon receptor axis in autoimmune diseases of the skin
Noakes, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85389-7.00009-0 · Cited by 2
Characterisation of Aicardi-Goutières syndrome
Krägeloh‐Mann, I. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70262-x · Cited by 2
Les maladies inflammatoires pédiatriques sont-elles toutes des maladies génétiques ?
Bélot, A. (2015) · Archives de Pédiatrie · doi:10.1016/j.arcped.2015.08.008 · Cited by 2
Juan, M. (2016) · MOJ Immunology · doi:10.15406/moji.2016.04.00113 · Cited by 2
“All SAVI patients show persistently high IFN signatures in the blood resembling other interferonopathies including the proteasome defect-associated autoinflammatory disease CANDLE [97], the AGS and TREX1-mediated familial childblain lupus [98].”
BackgroundThe Innate Immune System in SLE
Bossaller, L., & Marshak‐Rothstein, A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1893-5.00006-6 · Cited by 2
Crow, M. K., Kirou, K. A., & Niewold, T. B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47927-1.00012-8 · Cited by 2
Lhamtsho, D., Rajesh, U., Saxena, A., Bhardwaj, G., & Sondhi, V. (2020) · BMJ Neurology Open · doi:10.1136/bmjno-2019-000018 · Cited by 2
Systemic lupus erythematosus in children
Lewandowski, L. B., & Schanberg, L. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820583-9.00017-8 · Cited by 2
Amico, G., Hemphill, W. O., Severino, M., Moratti, C., Pascarella, R., Bertamino, M., Napoli, F., Volpi, S., Rosamilia, F., Signa, S., et al. (2022) · Genes · doi:10.3390/genes13071179 · Cited by 2
Self-citationCutaneous lupus erythematosus: insights from molecular pathogenesis to targeted therapies
Alduraibi, F. K., Goldsmith, J., & Chien, P. (2025) · Exploration of Immunology · doi:10.37349/ei.2025.1003222 · Cited by 1
Discordant phenotype caused by TREX1 variant in siblings with Aicardi-Goutières syndrome
Liu, R., Kretschmer, S., Switala, P., Attia, M., Lee‐Kirsch, M. A., & Wolf, C. (2025) · Pediatric Rheumatology · doi:10.1186/s12969-025-01168-2 · Cited by 1
Skin disease in cutaneous lupus erythematosus
Chong, B. F., & Werth, V. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-93232-5.00040-x · Cited by 1
Aicardi-Goutières Syndrome Type 1: A Novel Missense Variant and Review of the Mutational Spectrum.
Tasharrofi, B., Karimzadeh, P., Asadollahi, M., Hasani, S., Heidari, M., & Keramatipour, M. (2024) · Iranian journal of child neurology. · doi:10.22037/ijcn.v18i3.43274 · Cited by 1
New Phenotypes Associated With Pathogenic RNASEH2B and SAMHD1 Variants
Abdel‐Salam, G. M. H., Eid, M. M., El‐Serafy, M. A., El-Sayed, H. M., & Abdel‐Hamid, M. S. (2025) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.70019 · Cited by 1
The intersection of TREX1, cGAS, STING and the DNA damage theory of aging
Jones, K. M., Chauvin, S. D., & Miner, J. J. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1720372 · Cited by 3
“Thus, N-terminal TREX1 mutations result in hyperactivation of the cGAS-STING pathway, causing inflammatory diseases such as Aicardi-Goutières syndrome (AGS) and Familial chilblain lupus (FCL) (Wang et al., 2022; Rice et al., 2007; Liu and Ying, 2023).”
Genetic Testing in Clinical Immunology: What to Know and How to Do It
Yang, R., Chinn, I. K., Orange, J. S., & Peng, X. P. (2026) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2026.06.034 · Cited by 1
Tüngler, V., & Lee‐Kirsch, M. A. (2014) · Arthritis und Rheuma · doi:10.1055/s-0037-1617993 · Cited by 3
“Der familiäre Chilblain-Lupus wird durch heterozygote Mutationen im TREX1-Gen (CHBL1; OMIM 610448) verursacht (32, 52).”
BackgroundPathogenic aspects of hereditary small vessel disease of the brain
Joutel, A. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139382694.008 · Cited by 1
Recurrent chilblains in a child with neurological impairment
Mohandas, P., Bowker, R., Ravenscroft, J., & Bleiker, T. O. (2017) · Clinical and Experimental Dermatology · doi:10.1111/ced.13330 · Cited by 1
A Novel Mutation in Aicardi–Goutières' Syndrome: A Case Report
Sheikh‐Hosseini, M., Moarefzadeh, M., Alavi-Moghaddam, H., & Morovvati, S. (2020) · Journal of Pediatric Neurology · doi:10.1055/s-0040-1716910 · Cited by 2
Crow, M. K., Kirou, K. A., & Niewold, T. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-93232-5.00022-8 · Cited by 1
Reeves, W. H., Han, S., Zhuang, H., Xu, Y., Shumyak, S. P., Fisher, S. H., & Yang, L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801917-7.00023-1 · Cited by 1
Bielsa, I. (2012) · Seminarios de la Fundación Española de Reumatología · doi:10.1016/j.semreu.2011.12.003 · Cited by 1
Eleftheriou, D., Torrelo, A., & Brogan, P. A. (2019) · Springer eBooks · doi:10.1007/978-3-319-98605-0_24 · Cited by 3
Mendelian Disorders of Immunity Related to an Upregulation of Type I Interferon
Crow, Y. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405546-9.00028-5 · Cited by 1
Self-citationTREX1 mutations are not associated with sporadic inclusion body myositis
Cox, F. M. E., Boon, E. M. J., van der Lans, C., Bakker, E., Verschuuren, J. J. G. M., & Badrising, U. A. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02964.x · Cited by 1
“, Aicardi-Goutière, childblain lupus, and systemic lupus erythematosus.[2] Furthermore, Trex1 knockout mice were reported to spontaneously develop an inflammatory myocarditis.”
BackgroundNeuroimaging in Aicardi-Goutières syndrome: Biomarkers for a progressive encephalopathy
Uzgil, B., & Sherr, E. H. (2015) · Neurology · doi:10.1212/wnl.0000000000002227 · Cited by 1
“Thus, not only can autosomal dominant mutations in TREX1 lead to AGS, but these mutations can also lead to familial chilblain lupus, further strengthening this linkage to a progressive autoimmune disorder that could potentially be treated prior to symptoms.(8) Apropos of this linkage, a recent article showed that inac…”
BackgroundEnhanced Inflammatory Signaling Driven by Metabolic Switch in Aicardi-Goutières SyndromePreprint
Batignes, M., Luka, M., Jagtap, S., de Cevins, C., Nemazanyy, I., Fali, T., García-Paredes, V., Carbone, F., Pérot, B. P., Neven, B., et al. (2023) · SSRN Electronic Journal · doi:10.1101/2023.02.23.529707 · Cited by 1
Self-citationQuelles sont les particularités du lupus érythémateux de l'enfant ?
Bader‐Meunier, B. (2013) · Elsevier eBooks · doi:10.1016/b978-2-294-71447-4.50011-8
[Aicardi-Goutieres syndrome: a Mendelian mimic of congenital infection].
Lebon, P. (2009) · PubMed · doi:10.1684/vir.2009.0275
“Des mutations hétérozygotes dominantes dans le domaine catalytique de TREX1 sont la cause d’une maladie familiale lupique associée à une forme cutanée atteignant les extrémités des doigts, les oreilles et les dents [22, 23].”
BackgroundSviluppo di carcinoma timico in paziente affetta da Chilblain Lupus (CHLE): studio di un caso
Bertoldo, F., Cattrini, B., Vassallo, C., & Borroni, G. (2011) · Università degli Studi di Pavia · doi:10.6092/2039-1404.124.901
“pus sistemico e nella sindrome di Aicardi-Goutieres (A GS) [9].”
BackgroundLupus sistémico y dermatomiositis infantil
Bader‐Meunier, B., & Bodemer, C. (2013) · EMC - Pediatría · doi:10.1016/s1245-1789(13)65865-5
Properties of autonomous 3′→5′ exonucleases
Krutyakov, V. M. (2009) · Biochemistry (Moscow) · doi:10.1134/s000629790908001x
Klinische Symptome und Pathogenese der Typ-1-Interferonopathien
Diesterheft, M., Schuster, M., Rösen‐Wolff, A., Berner, R., Tüngler, V., & Lee‐Kirsch, M. A. (2015) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-015-3478-5
Self/Non-self Discrimination by Toll-like Receptor 9
Mouchess, M. L. (2011) · eScholarship (California Digital Library)
Lupus systémique et dermatomyosites de l’enfant
Bader‐Meunier, B., & Bodemer, C. (2013) · EMC - Pédiatrie - Maladies infectieuses · doi:10.1016/s1637-5017(13)61598-7
DNA repair defects as a mechanism contributing to the development of lupus.
Xu, J. (2013) · OhioLink ETD Center (Ohio Library and Information Network)
Complex Genetic Control of Autoimmune Disease
Bull, K. R., & Cornall, R. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.15009-x
Wisłowska, M. (2016) · MOJ Orthopedics & Rheumatology · doi:10.15406/mojor.2016.05.00187
“An important role in the development of disease attributed to genetic factors [2-7] (including antigens HLA class II DR2, DR3 [8], but many other genes outside of this system) [4,9-14], hormones, [15-17] (estrogen effects [18-21] and prolactin inducing autoimmune response), environmental factors [22] (exposure to ultr…”
BackgroundNucleic Acid Detection in Anti-Viral Responses and Autoimmunity
Brunette, R. L. (2012) · ResearchWorks at the University of Washington (University of Washington)
GENETIC STUDIES ON FINNISH LUPUS ERYTHEMATOSUS PATIENTS WITH CUTANEOUS MANIFESTATIONS
Järvinen, T. M. (2010) · Helda - University of Helsinki Institutional Repository
Faculty Opinions recommendation of Activation of STING requires palmitoylation at the Golgi.
Welch, M. D., & Burke, T. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726438534.793554041
Kiener, S., Ribi, C., Keller, I., Chizzolini, C., Trendelenburg, M., Huynh‐Do, U., von Kempis, J., (SSCS), O. B. O. S. S. C. S., & Leeb, T. (2021) · Genes · doi:10.3390/genes12081268
“Genes affected in such patients include DNASE1 [12] and TREX1 [13].”
BackgroundFaculty Opinions recommendation of Trex1 prevents cell-intrinsic initiation of autoimmunity.
Caricchio, R., & Gallucci, S. (2008) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1123908.584049
Immunogenetic markers as prognostic tools for the management of various human diseases
Ali, A., Sheikh, I. M., Bashir, S. M., Bhat, M. S., Malla, B. A., & Ganie, S. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90250-2.00006-6
Reeves, W. H., Han, S., & Zhuang, H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814551-7.00026-x
Happle, R. (2009) · Fortschritte der praktischen Dermatologie und Venerologie · doi:10.1007/978-3-540-77148-7_61
Concha, J. S. S., & Werth, V. P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820583-9.00008-7
Disorders of Nucleotide Metabolism
Lee‐Kirsch, M. A., Tüngler, V., Orcesi, S., & Tonduti, D. (2022) · Springer eBooks · doi:10.1007/978-3-030-67727-5_14
STING signaling modulates CD8 T cell memory fitness via differential TCR signaling
Quaney, M. J. (2022) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/91618
Vejvisithsakul, P. P., Wanachate, S., Ngamjanyaporn, P., Thumarat, C., Suangtamai, T., Leelahavanichkul, A., Hirankan, N., Pisitkun, T., Paludan, S. R., & Pisitkun, P. (2022) · medRxiv · doi:10.1101/2022.12.02.22283012
Nanjundagowda, V. K., Paikaraya, S., Srinivasan, V. M., & Srivastava, A. (2023) · Cureus · doi:10.7759/cureus.40366
“The disease is mostly inherited in an autosomal recessive manner except for AGS1 and AGS6 caused due to mutations in TREX1, ADAR that can have both recessive and dominant inheritance, and AGS7 caused due to mutations in IFIH1 inherited in an autosomal dominant manner [4-6].”
BackgroundBélot, A., Tusseau, M., & Bader‐Meunier, B. (2022) · Elsevier eBooks · doi:10.1016/b978-2-294-77580-2.00023-2
Lupus Erythematosus and Antiphospholipid Syndrome
Dutz, J. P., & Khosravi‐Hafshejani, T. (2024) · Wiley eBooks · doi:10.1002/9781119709268.rook051
Additional file 1 of Deficiency of Trex1 leads to spontaneous development of type 1 diabetes
Zhao, J., Su, Z.-H., Han, Q., Wang, M., Liu, X., Li, J., Huang, S., Chen, J., Li, X., Chen, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24934234
Single gene defects and autoinflammation
Moore, R. E., Hagiwara, A. M., & Jefferies, C. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-93232-5.00015-0
Domsic, R. T., & Paik, J. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-52581-0_10
Lu, Q., Tian, J., & Chang, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00063-1
Neurological Impact of Type I Interferon Dysregulation
Mylonas, A. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1006023
Laurent, A., Ranchin, B., Khaldi-Plassart, S., & Bélot, A. (2024) · EMC - Pediatría · doi:10.1016/s1245-1789(24)47447-7
Typ-1-Interferonopathien: Ein Update
Wege, L., & Lee‐Kirsch, M. A. (2024) · Arthritis und Rheuma · doi:10.1055/a-2352-7224
Systemic Autoinflammatory Diseases
Peng, X. P., Schnappauf, O., de Jesus, A. A., & Aksentijevich, I. A. (2024) · Wiley eBooks · doi:10.1002/9781683674023.ch70
Cho, L. K., Bakowsky, V., & Legge, A. C. (2025) · The Journal of Rheumatology · doi:10.3899/jrheum.2024-1231
Complex Genetic Control of Autoimmune Disease
Droscher, E., & Bull, K. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00251-9
Immunologic, Reactive, and Purpuric Disorders
Baselga, E., Hernández‐Martín, A., & Torrelo, A. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-2638-7.00020-1 · Cited by 1
Additional file 3 of Deficiency of Trex1 leads to spontaneous development of type 1 diabetes
Zhao, J.-M., Su, Z.-H., Han, Q.-Y., Wang, M., Liu, X., Li, J., Huang, S.-Y., Chen, J., Li, X.-W., Chen, X.-Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26659087
Additional file 2 of Deficiency of Trex1 leads to spontaneous development of type 1 diabetes
Zhao, J.-M., Su, Z.-H., Han, Q.-Y., Wang, M., Liu, X., Li, J., Huang, S.-Y., Chen, J., Li, X.-W., Chen, X.-Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24934671
Yi, C., Li, Q., & Xiao, J. (2020) · Figshare · doi:10.6084/m9.figshare.12134214
Xie, N., Sun, Q., Yang, J., Zhou, Y., Xu, H., Zhou, L., & Zhou, Y. (2021) · Figshare · doi:10.6084/m9.figshare.13669404
Additional file 4 of Deficiency of Trex1 leads to spontaneous development of type 1 diabetes
Zhao, J.-M., Su, Z.-H., Han, Q.-Y., Wang, M., Liu, X., Li, J., Huang, S.-Y., Chen, J., Li, X.-W., Chen, X.-Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26659090
Additional file 5 of Deficiency of Trex1 leads to spontaneous development of type 1 diabetes
Zhao, J.-M., Su, Z.-H., Han, Q.-Y., Wang, M., Liu, X., Li, J., Huang, S.-Y., Chen, J., Li, X.-W., Chen, X.-Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26659093
Clinical and molecular characterisation of type I interferonopathies
Melki, I. (2017) · theses.fr (ABES) · doi:10.70675/56be76a9z1a05z4438zabf7zaf769da7e2fc · Cited by 1
Clinical and molecular characterisation of the type I interferonopathies and approaches to therapy
Frémond, M. (2018) · theses.fr (ABES) · doi:10.70675/a5e8252azb7f7z4f38zb08dzd8e8c7df0db2
Gentili, M. (2017) · theses.fr (ABES) · doi:10.70675/93617cb4za4e9z4fdez831az0bf2b31aea90
New genetic predisposition to early-onset autoimmunity in human : implication of the NF-κB pathway
Barnabei, L. (2019) · theses.fr (ABES) · doi:10.70675/59eeec14zbe5fz4f23zae93z2575171fe00b
Les NETs (Neutrophils Extracellular Traps) et les DNases au cours de la COVID-19
Garcia, G. (2024) · theses.fr (ABES) · doi:10.70675/966d76edz52a6z40c0z8f18z57c699067db5
Étude de la fonction de la DNASE1L3 en contexte auto-immun et anti-tumoral
Santa, P. (2024) · theses.fr (ABES) · doi:10.70675/2af1f0cfz45caz418azb93ez88367c4a54c8
Rosenfeld, E. B., Kasatkin, N., Yu, B. L., Velinov, M. T., Brandt, J. S., & Ashkinadze, E. (2026) · Pregnancy · doi:10.1002/pmf2.70280 · Cited by 1
From Genes to Pathways: The Molecular Landscape of Systemic Lupus Erythematosus
Rashid, R., & Ramirez‐Ortiz, Z. G. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104552
“Polymorphisms in immune-related genes, including IRF5, TYK2, and CTLA4, have been associated with CLE subtypes, while rare forms such as familial chilblain lupus result from gain-of-function mutations in STING [187,188] or loss-of-function mutations in TREX1 [185,189–191].”
Metadata
- Authors
- Rice, G., Newman, W. G., Dean, J., Patrick, T., Parmar, R., Flintoff, K., Robins, P., Harvey, S., Hollis, T., O’Hara, A., Herrick, A. L., Bowden, A. P., Perrino, F. W., Lindahl, T., Barnes, D. E., & Crow, Y. J.
- Affiliations
- St James's University Hospital (GB)
- St Mary's Hospital (GB)
- National Health Service (GB)
- Cancer Research UK (GB)
- Wake Forest University Health Sciences (US)
- Royal Aberdeen Children's Hospital (GB)
- Salford Royal Hospital (GB)
- Rochdale Infirmary (GB)
- Corresponding author
- Crow, Yanick J.
- ORCID
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 80
- Issue
- 4
- Pages
- 811-815
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1852703
- OpenAlex
- W2171946670
- Cited by
- 410
- References
- 24
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 37 · 2023: 13 · 2022: 22 · 2021: 31 · 2020: 19 · 2019: 17 · 2018: 15 · 2017: 20 · 2016: 19 · 2015: 25 · 2014: 26 · 2013: 31 · 2012: 28
- FWCI
- 15.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2301 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (R01GM069962, GM 069962)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- TREX1, chilblain lupus, Aicardi-Goutières syndrome, heterozygous mutation, de novo mutations, 3'-5' exonuclease, systemic lupus erythematosus, autoinflammatory disease, catalytic residues
- MeSH terms
- Basal Ganglia Diseases, Base Sequence, Cell Line, Exodeoxyribonucleases, Female, Humans, Lupus Erythematosus, Systemic, Male, Molecular Sequence Data, Mutation, Pedigree, Phosphoproteins, Syndrome, Sequence Analysis, DNA, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.